Oxcarbazepine

Oxcarbazepine is approved for use as a monotherapy or adjunctive therapy for the treatment of partial seizures in adults and children aged 4 years and older. It helps to reduce the occurrence and severity of seizures by stabilizing electrical activity in the brain.